Deutsche Bank downgraded AstraZeneca (NYSE:AZN) to "hold" from "buy", according to MarketWatch.
Lehman Brothers reiterated its "overweight" rating on Apple (NASDAQ:AAPL) ahead of the 3G iPhone going on sale, according to the AP.
UBS downgraded Merck (NYSE:MRK) from "buy" to "neutral", according to Briefing.com. The news service also reports that Piper Jaffray upgraded Broadcom (NASDAQ:BRCM) to "buy" from "neutral."
Douglas A. McIntyre is an editor at 247wallst.com.











Add your comments